FNDR-20123 is a potent, safe, and first-in-class antimalarial HDAC inhibitor; it exhibits antimalarial activity against both the asexual blood stages (IC50 = 41 nM) and sexual stages (male gametocytes, IC50 = 190 nM) of Plasmodium falciparum; it inhibits human HDAC isoforms HDAC1, HDAC2, HDAC3, HDAC6, and HDAC8 with IC50 values of 25, 29, 2, 11, and 282 nM, respectively, and also inhibits class III HDAC subtypes at nanomolar concentrations.